Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4726 to 4740 of 8218 results

  1. System-level factors and the risk of dependence: Do system-level factors, such as training received by prescribers alter the risk of developing problems associated with dependence on prescribed medicines?

    Recommendation ID NG215/06 Question System-level factors and the risk of dependence: Do system-level factors, such as training received

    Research recommendation
    Published
    11 May 2022

  2. E-cigarette flavours: Do the flavours used in nicotine-containing e‑cigarettes have an impact on their effectiveness as an aid to stopping smoking, and are there any adverse effects associated with them?

    Recommendation ID NG209/08 Question E-cigarette flavours: Do the flavours used in nicotine-containing e‑cigarettes have an impact on their

    Research recommendation
    Published
    17 December 2021

  3. Symptoms and signs of recurrent UTI:  Do the symptoms and signs of UTI in babies, children and young people aged under 16 years differ in those with a history of recurrent UTIs compared with those without a history of recurrent UTI?

    Recommendation ID NG224/03 Question Symptoms and signs of recurrent UTI: Do the symptoms and signs of UTI in babies, children and young

    Research recommendation
    Published
    4 August 2022

  4. Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants should only be used in the context of research. Research should aim to establish the risk of secondary haemorrhage and its consequences, and the need for shunt insertion. Outcomes should include death and disability in the long-term: these should be reported separately.

    Recommendation ID IPG412/1 Question Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm

    Research recommendation
    Published
    9 June 2015

  5. What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over with an acute coronary syndrome, who are having percutaneous coronary intervention (PCI)?

    Recommendation ID NG185/1 Question What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over

    Research recommendation
    Published
    22 January 2021

  6. In patients with negative MRI (Likert score 1 or 2), what is the next best diagnostic investigation to rule out clinically significant prostate cancer? What is the diagnostic accuracy of transperineal mapping biopsy compared with transperineal non-mapping biopsy in the diagnosis of clinically significant prostate cancer?

    Recommendation ID NG131/7 Question In patients with negative MRI (Likert score 1 or 2), what is the next best diagnostic investigation

    Research recommendation
    Published
    25 October 2019

  7. What is the prognostic value of different risk stratification methods for people with locally advanced prostate cancer?

    Recommendation ID NG131/7 Question What is the prognostic value of different risk stratification methods for people with locally advanced

    Research recommendation
    Published
    25 October 2019

  8. Apart from culture, what other diagnostic tests or combinations of tests are effective inestablishing an accurate diagnosis of active respiratory TB in children and young people withsuspected active TB?

    Recommendation ID NG33/2 Question Apart from culture, what other diagnostic tests or combinations of tests are effective inestablishing

    Research recommendation
    Published
    8 November 2019

  9. What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?

    Recommendation ID NG131/3 Question What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate

    Research recommendation
    Published
    25 October 2019

  10. Primary care testing: Diagnostic accuracy studies of tests accessible to primary care should be carried out for a given cancer in symptomatic people. Priority areas for research should include tests for people with cough, non-visible haematuria, suspected prostate cancer, suspected pancreatic cancer, suspected cancer in childhood and young people and other suspected rare cancers. Outcomes of interest are the performance characteristics of the test, particularly sensitivity, specificity and positive and negative predictive values.

    Recommendation ID NG12/02 Question Primary care testing: Diagnostic accuracy studies of tests accessible to primary care should be carried

    Research recommendation
    Published
    7 January 2022

  11. Diagnostic investigations to predict treatment outcomes:- What is the prognostic value of the Hevylite assay and ratio compared with other prognostic factors and tests, including the serum-free light-chain assay and fluorescence in-situ hybridisation (FISH), in people with newly diagnosed myeloma who are starting treatment?

    Recommendation ID NG35/1 Question Diagnostic investigations to predict treatment outcomes:- What is the prognostic value of the Hevylite

    Research recommendation
    Published
    5 April 2016

  12. What is the effect of dietary interventions or dietary changes on acne?

    Recommendation ID NG198/3 Question What is the effect of dietary interventions or dietary changes on acne? Any explanatory notes(if

    Research recommendation
    Published
    3 May 2024

  13. Risk prediction tool for second seizure: Development of a risk prediction tool for second seizures in people with a single seizure, and an external validation of a risk prediction tool to detect the probability of a second seizure in people with a single seizure at baseline.

    Recommendation ID NG217/09 Question Risk prediction tool for second seizure: Development of a risk prediction tool for second seizures

    Research recommendation
    Published
    11 May 2022

  14. Risk prediction tool for all-cause epilepsy-related death: Development of a risk prediction tool to detect all-cause mortality including sudden unexpected death in epilepsy (SUDEP) in people with epilepsy or those who have had a single seizure, and an external validation of a risk prediction tool to detect the probability of epilepsy-related death.

    Recommendation ID NG217/03 Question Risk prediction tool for all-cause epilepsy-related death: Development of a risk prediction tool to

    Research recommendation
    Published
    11 May 2022

  15. What is the clinical effectiveness of maggot debridement therapy in the debridement of diabetic foot ulcers?

    Recommendation ID NG19/10 Question What is the clinical effectiveness of maggot debridement therapy in the debridement of diabetic foot

    Research recommendation
    Published
    18 November 2019